NCT07223580PHASE4Recruiting
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
Mayo Clinic
Start Date
1/23/2026
Completion Date
12/1/2027
Summary
The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Patients who are diagnosed with kidney or ureteral stones confirmed on imaging (CT of the abdomen or pelvis) and who elect for definitive treatment via ureteroscopy with placement of ureteral stent.
* Age 18 years or older
* Patients of either gender
* Patients of all ethnic backgrounds
* Cable of giving informed consent
* Capable and willing to fulfill the requirements of the study.
Exclusion Criteria:
* History of chronic pain
* Chronic use of opioids or other pain medication (\>12 weeks)
* Known allergies to corticosteroids.
* Known or suspected pregnancy
* Inability to give informed consent or unable to meet requirements of the study for any reason.
* Bilateral ureteroscopy
* Current Corticosteroid Use
* Diabetic patients who are insulin dependent
Interventions
DRUG
Corticosteroid
OTHER
Placebo
Conditions
UreteroscopyPost Operative Pain
Locations
Mayo Clinic in Arizona
Scottsdale, Arizona 85259
United States